United States · 
Who invested in Amberstone Biosciences?
Amberstone Biosciences's investors include National Science Foundation and Sinovation Ventures.
United States · Series A startup
Who invested in Amberstone Biosciences
Funding summaryUpdated 26 Oct 2026
$12Mraised across 1 round since 2022, from 1 source
- Latest round
- Series A, $12MJan 2022
- Investors
- 2
The rounds
- Jan 2022Series A$12M
Source recordedSEC filing: $6.0M sold, first sale Nov 2021
Founders and team
From Amberstone Biosciences's own website and the SEC filings it signed: 4 on the team.
- George Guikai WuCEO & Cofounder
- Scott StromattChief Medical Officer
- Aude SegalinyVP, Research and Early Development
- Yonglei Guikai ShangExecutive Officer, Directori
On the board, as filediWeian Guikai Zhao
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Amberstone Biosciences
How much has Amberstone Biosciences raised?
Amberstone Biosciences has raised $12M across 1 round since 2022.
When did Amberstone Biosciences last raise?
Amberstone Biosciences's most recent round was a Series A of $12M in Jan 2022.
What was Amberstone Biosciences's biggest round?
Its most recent round, $12M in Jan 2022, is also its largest on record.
Who backed Amberstone Biosciences first?
Amberstone Biosciences's first round on record, in Jan 2022, was backed by National Science Foundation and Sinovation Ventures.
What stage is Amberstone Biosciences at?
Amberstone Biosciences's latest named round is a Series A, in Jan 2022.
Where is Amberstone Biosciences based?
Amberstone Biosciences is based in the United States.
Companies like Amberstone Biosciences
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.